LYZL2 activators are a category of chemical compounds that interact with and modulate the activity of the enzyme lysozyme-like 2 (LYZL2). This enzyme is a member of the c-type lysozyme/alpha-lactalbumin family, characterized by their ability to catalyze the hydrolysis of certain components in bacterial cell walls. LYZL2, specifically, is a protein that shares homology with the well-studied lysozyme, which is known for its role in the innate immune system as a bacteriolytic factor. The activators of LYZL2 can bind to the enzyme and induce a conformational change that either enhances or initiates its catalytic function. The precise mechanism of action for these activators is often complex and may involve alterations in the enzyme's substrate affinity, its turnover rate, or stabilization of its active form. These changes at the molecular level affect the enzyme's natural function, which is to break down the structural components in bacterial cell walls, thereby compromising the integrity of the bacterial cell.
At the biochemical level, LYZL2 activators are varied in structure and composition, reflecting the diverse approaches used to modulate enzyme activity. These compounds may be small molecules, peptides, or other types of chemical agents specifically designed to interact with the active site or allosteric sites of the enzyme. The design of LYZL2 activators is often informed by detailed knowledge of the enzyme's structure, including the spatial arrangement of its active site and surrounding regions. By binding to these sites, activators can influence the enzyme's spatial conformation and charge distribution, which in turn can lead to an increase in enzymatic activity. The study of such activators involves a combination of techniques, including computational modeling, structure-activity relationship studies, and experimental assays to determine the efficacy of binding and activation. The identification and development of these activators rely on advanced methods in biochemistry and molecular biology to elucidate their interaction with the enzyme at a detailed level, paving the way for a deeper understanding of the enzyme's role and regulation within biological systems.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin directly stimulates adenylate cyclase, increasing cAMP levels in cells. Elevated cAMP activates PKA, which can phosphorylate and thereby enhance the activity of LYZL2 by influencing its post-translational modification and function in sperm maturation and function. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is a cell-permeable cAMP analog that activates PKA. Activation of PKA can lead to phosphorylation and subsequent activation of LYZL2, impacting its role in the reproductive system. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-specific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP. The resulting increase in cAMP levels can enhance LYZL2 activity indirectly through PKA activation. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its G-protein-coupled receptors to increase intracellular cAMP, which in turn activates PKA and can enhance LYZL2 activity through phosphorylation processes. | ||||||
Manganese(II) chloride beads | 7773-01-5 | sc-252989 sc-252989A | 100 g 500 g | $19.00 $31.00 | ||
Manganese(II) chloride is an activator of adenylate cyclase, leading to increased cAMP levels and subsequent PKA activation. This can indirectly enhance LYZL2 activity by affecting its phosphorylation state. | ||||||
Zinc | 7440-66-6 | sc-213177 | 100 g | $48.00 | ||
Zinc is essential for the proper function of many enzymes; it may enhance LYZL2 activity by stabilizing the protein structure and maintaining its catalytic activity, which is crucial for its function in spermatozoa. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that increases cAMP levels by activating adenylate cyclase. This rise in cAMP can lead to PKA activation and subsequent enhancement of LYZL2 activity. | ||||||
L-Arginine | 74-79-3 | sc-391657B sc-391657 sc-391657A sc-391657C sc-391657D | 5 g 25 g 100 g 500 g 1 kg | $20.00 $31.00 $61.00 $219.00 $352.00 | 2 | |
L-Arginine can lead to the production of nitric oxide (NO), which has been shown to modulate cAMP levels, possibly enhancing LYZL2 activity through cAMP-dependent pathways. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), which increases cAMP levels in the cell, thereby potentially enhancing LYZL2 activity through PKA-dependent phosphorylation. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
S-Nitroso-N-acetylpenicillamine (SNAP) releases nitric oxide (NO), which can influence cAMP levels and thus activate PKA, potentially leading to the enhancement of LYZL2 activity. | ||||||